current publications

Current Publications

PUBLICATION LIST 2017
Therapy resistance mediated by cancer stem cells.

Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II.. Semin Cancer Biol 2018, 53:156-167

Special Issue "Cancer Stem Cells: Impact on Treatment".

Skvortsova I.. Semin Cancer Biol 2018, 53:iii-iv

RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation.

Liccardi G, Ramos Garcia L, Tenev T, Annibaldi A, Legrand AJ, Robertson D, Feltham R, Anderton H, Darding M, Peltzer N, Dannappel M, Schünke H, Fava LL, Haschka MD, Glatter T, Nesvizhskii A, Schmidt A, Harris PA, Bertin J, Gough PJ, Villunger A et.al.. Mol Cell 2018, 73(3):413-428.e7

Evaluation of Vav3.1 as prognostic marker in endometrial cancer.

Boesch M, Sopper S, Marth C, Fiegl H, Wiedemair A, Rössler J, Hatina J, Wolf D, Reimer D, Zeimet AG.. J Cancer Res Clin Oncol 2018, 144(10):2067-2076

In the beginning, there was chaos: A perspective on the development of immuno-oncological biomarkers.

Salgado R, Harris L, Skvortsova I, Denkert C, Loi S.. Semin Cancer Biol 2018, 52(Pt 2):v-vi

Flow Cytometry: To Dump or Not To Dump.

Boesch M, Cosma A, Sopper S.. J Immunol 2018, 201(7):1813-1815

The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma.

Steiner N, Hajek R, Sevcikova S, Borjan B, Untergasser G, Göbel G, Gunsilius E.. Anticancer Res 2018, 38(9):5087-5092

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets.

Steiner N, Müller U, Hajek R, Sevcikova S, Borjan B, Jöhrer K, Göbel G, Pircher A, Gunsilius E.. PLoS One 2018, 13(8):e0202045

CD8+HLADR+ Regulatory T Cells Change With Aging: They Increase in Number, but Lose Checkpoint Inhibitory Molecules and Suppressive Function.

Lukas Yani S, Keller M, Melzer FL, Weinberger B, Pangrazzi L, Sopper S, Trieb K, Lobina M, Orrù V, Fiorillo E, Cucca F, Grubeck-Loebenstein B. Front Immunol 2018, 9:1201

Prostate Cancer Stem Cells: Current Understanding

Skvortsov S, Skvortsova II, Tang DG, Dubrovska A. Stem Cells. 2018 May 30 2018, [Epub ahead of print]

(Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer.

Boesch-M, Reimer D, Sopper S, Wolf D, Zeimet AG. Oncologist 2018, doi: 10.1634/theoncologist.2017-0683

Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.

Klepsch V, Hermann-Kleiter N, Do-Dinh P, Jakic B,Offermann A, Efremova M, Sopper S, Rieder D, Krogsdam A, Gamerith G, Perner S, Tzankov A, Trajanoski Z, Wolf D, Baier G. Nat Comm 2018, 9(1):1538

Concise Review: Aggressive Colorectal Cancer: Role of Epithelial Cell Adhesion Molecule in Cancer Stem Cells and Epithelial-to-Mesenchymal Transition.

Boesch M, Spizzo G, Seeber A. Stem Cell Transl Med 2018, doi: 10.1002/sctm.17-0289. [Epub ahead of print]

Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response

Reimer D, Boesch M, Wolf D, Marth C, Sopper S, Hatina J, Altevogt P, Parson W, Hackl H, Zeimet AG. Int J Cancer 2018, 142(8):1640-1651

Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.

Reimer D, Boesch M, Wolf D, Marth C, Sopper S, Hatina J, Altevogt P, Parson W, Hackl H, Zeimet AG. Int J Cancer 2018, 142(8):1640-1651

Anti-tumour active gold(i), palladium(ii) and ruthenium(ii) complexes with thio- and selenoureato ligands: a comparative study.

Molter A, Kathrein S, Kircher B, Mohr F. Dalton Trans 2018, 47(14):5055-5064

Chlorinated cobalt alkyne complexes derived from acetylsalicylic acid as new specific antitumor agents.

Obermoser V, Baecker D, Schuster C, Braun V, Kircher B, Gust R. Dalton Trans 2018, 47(12):4341-4351

BOK promotes chemical-induced hepatocarcinogenesis in mice

Rabachini T, Fernandez-Marrero Y, Montani M, Loforese G, Sladky V, He Z, Bachmann D, Wicki S, Villunger A, Stroka D, Kaufmann T. Cell Death Differ 2018, 25(4):706-718